Simultaneously, nanoparticles encapsulating innate immune stimulants proved sufficient to increase the activation of neoantigen‐specific CD8+ T cells, resulting in robust suppression of tumour progression in PDTOs.122. This evidence concerns the gene CD8A and neoplasm.